Company / Depreciation & Amortization
Arcturus Therapeutics Holdings Inc. Depreciation & Amortization History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$3.0M
FY2025
5-year range
$1.2M / $3.5M
FY2021-FY2025
Trend
-14.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $3M to $3M over the past 2 years.
Based on SEC 10-K filings.
$3M in FY2025 with a 5-year CAGR of +39.0%.
Increased from $3M to $3M over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +36.4%
- 5-Year CAGR
- +39.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +39.0%, indicating consistent growth.
- In FY2025, depreciation & amortization decreased 14.6% year-over-year.
- Peak depreciation & amortization was recorded in FY2024.
- Lowest depreciation & amortization in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.06 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.0M | -14.6% |
| FY2024 | $3.5M | +19.9% |
| FY2023 | $3.0M | +147.9% |
| FY2022 | $1.2M | +0.0% |
| FY2021 | $1.2M | +105.0% |
| FY2020 | $582.0K | +0.0% |
| FY2019 | $582.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026